Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CENPJ | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | NXNL2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | BRD4 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | ZNF414 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | CYB5R1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | BAK1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | PRRC2B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | RRP7A | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |
mRNA | USP42 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | PPRC1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |